Optimal frequency in extracorporeal shock wave lithotripsy: prospective randomized study
Urology · 2005 · Vol. 66 · Issue 6 · 1160-1164
Academy Summary
Optimal frequency in extracorporeal shock wave lithotripsy: prospective randomized study examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Treatment Optimisation.
The investigators used a Prospective Randomized Controlled Trial in adults undergoing swl for kidney stones. This design strengthens comparison between the treatment strategies studied, although the conclusions still remain tied to the lithotripter, protocol and eligibility criteria used.
A prospective randomized comparison of 60, 90 and 120 shocks/min found better efficacy at the slower rates, with 90 shocks/min offering a practical balance between efficacy and treatment duration.
Shock-wave rate changes the effectiveness of each shock, not only the duration of the procedure.
The rate literature is central to modern SWL optimisation because it demonstrates that treatment speed and treatment efficiency are not synonymous. Slower delivery can allow cavitation bubbles to dissipate and may improve fragmentation efficiency, although the optimal rate must balance efficacy and treatment time.
Published in 2005, the study predates several contemporary refinements in SWL technique. The clinical principle remains relevant, but absolute rates and machine settings should be interpreted in their technological era.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
